Data / Form D filings / FIBROGEN INC
FIBROGEN INC: Form D filing
FIBROGEN INC, a pharmaceuticals company in San Francisco, CA, filed a Form D with the SEC in 2014. The latest, on December 10, 2014, reports $20 million sold of a $20 million offering to 1 investor.
Find out what FIBROGEN INC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 409 ILLINOIS STREET, San Francisco, CA, 94158
- Phone
- (415) 978-1200
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 921299
The full lists. Form D filings in California: 5,891 rows, $138.91, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Dec 10, 2014 | New notice | $20,000,000 | $20,000,000 | $0 | 1 | Nov 19, 2014 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Frank H. Valone | Executive Officer | |
| Thomas F. Kearns | Director | |
| K. Peony H. Yu | Executive Officer | |
| Jorma Pedro Routti | Director | |
| Miguel F. Madero | Director | |
| Rory B. Riggs | Director | |
| Toshinari N. Tamura | Director | |
| Kalevi F. Kurkijarvi | Director | |
| Julian N. Stern | Director | |
| Thomas B. Neff | Executive Officer, Director | |
| James A. Schoeneck | Director | |
| Pat B. Cotroneo | Executive Officer | |
| Roberto Pedro Rosenkranz | Director |
Other pharmaceuticals companies in California that filed recently
- Anvion Bio, Inc. $100,000 · Oct 7, 2026
- Aqur Biosciences, Inc. $1.5 million · Sep 18, 2026
- BTB Therapeutics, Inc. $8.9 million · Aug 12, 2026
Every Form D from the week of Dec 8, 2014 · All recent filings in California · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what FIBROGEN INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.